Startups

INBRAIN Neuroelectronics

Barcelona, Spain

INBRAIN Neuroelectronics S.L., private clinical-stage developer of graphene-based bidirectional neural interfaces and neuromodulation. Investigational products. Carolina Aguilar is CEO/co-founder; founding accounts differ between 2019 and 2020.

Team

Ana ChampetierVP product strategy and commercialization

Ane LizarazuHead PMO

Antòn GuimeràCo-founder

Bill PhillipsHead engineering

Carolina AguilarCEO / co-founder

Dan GnansiaHead clinical

Eduard RosInterim CFO

Javier CastilloVP quality/regulatory/market access

Jerome CroccoCOO

Joan AdanVP operational finance

Jose GarridoChief technology advisor / co-founder

Jurriaan BakkerCTO

Kostas KostarelosChair, vision board / co-founder

Matteo DonegaVP translational science and intelligence

Michel DecréTechnology and People Advisor

Willem KoendersHead commercialization

Investments

$50M2024-10-29	imec.xpand, EIC Fund, Fond ICO Next Tech, CDTI-Innvierte, Avançsa, Asabys Partners, Aliath Bioventures, Vsquared Ventures, Herbert Mangesius
€20M2023-12-11	European Investment Bank
€14M2021-03-26	Asabys Partners, Aliath Bioventures, Alta Life Sciences, Vsquared Ventures, TruVenturo, CDTI-Innvierte, Herbert Mangesius, CDTI
€900K2020-06-15	Asabys Partners, Alta Life Sciences, Aliath Bioventures, Institut Català de Finances, Finaves, BStartup
$—Unknown date	Mayo Clinic
€3MUnknown date	0 participations

team@apexlogos.ai4 hours ago
BCI research snapshot, reviewed 2026-10-06. Company identity: InbrainNeuroelectronics. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts. Part 1/1 # INBRAIN Neuroelectronics Accessed: 2026-10-06. Research report for human review; no database changes made. Direct image URLs are extracted source assets, not invented filenames. Funding ledger is verified events found, not a complete lifetime total. ## Identity and pasted claims [INBRAIN Neuroelectronics S.L.](https://www.inbrain.tech/) is a private clinical-stage graphene neural-interface company in Barcelona, Spain. Current official contact lists Av. Diagonal 615, sixth floor, 08028 Barcelona. Founding year requires reconciliation: initial spinout accounts use 2019, current company timeline uses 2020. Do not silently pick one as an incorporation date. Carolina Aguilar CEO, Barcelona and active clinical-stage classification pass. Company pages explicitly reserve devices for investigational use until market approval; breakthrough designation is not approval. Graphene-based bidirectional BCI and neuromodulation technology are real. Pasted $60M+ is directionally below the company’s USD68M disclosed at the 2024 SeriesB; current CEO biography says over USD100M raised but supplies no round-level reconciliation. Use sourced rounds and an explicitly dated total, not an inferred current total. [Current team](https://www.inbrain.tech/inbrain-team/), [investor SeriesB announcement](https://asabys.com/inbrain-neuroelectronics-raises-50m-series-b-to-advance-graphene-based-brain-computer-interface-technology/). ## Logo, founders and current public leadership Logo direct URL: https://v2.inbrain-neuroelectronics.com/wp-content/themes/igeneve_starter/images/Inbrain-Electronics-header-logo.svg — image source from [legacy official team site](https://v2.inbrain-neuroelectronics.com/team/). Legacy images are usable identity references but legacy titles are not current roles. Current role source is the [2026 official team page](https://www.inbrain.tech/inbrain-team/). | Person | Role / currency | Profile and evidence | Direct pfp URL | |---|---|---|---| | Carolina Aguilar | CEO / co-founder | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/07/Linkedin-300x300.jpg | | Jurriaan Bakker | CTO | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/07/Jurriaan-Bakker.jpg | | Jose Garrido | Chief technology advisor / co-founder; old CSO title superseded | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/07/Jose-A-Garrido.jpg | | Kostas Kostarelos | Chair, vision board / co-founder | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/08/Kostas-Kostarelos-300x300.png | | Antòn Guimerà | Co-founder | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/07/Anton-Guimera-300x300.jpg | | Jerome Crocco | COO | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/06/Jerome-Crocco-300x300.png | | Eduard Ros | Interim CFO | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/07/Eduard-Ros-300x300.png (actual current team image link) | | Ane Lizarazu | Head PMO | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/06/Ane-Lizarazu-236x300.jpg | | Ana Champetier | VP product strategy and commercialization | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/06/Ana-Champetier-236x300.png | | Willem Koenders | Head commercialization | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/06/Willem-Koenders-236x300.png (actual current team image link) | | Matteo Donega | VP translational science and intelligence | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/09/Matteo-300x300.png (actual current team image link) | | Dan Gnansia | Head clinical | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/09/Dan-Gnasio-300x300.png (actual current team image link) | | Bill Phillips | Head engineering | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2026/06/Bill-Phillips-300x300.jpg (actual current team image link) | | Javier Castillo | VP quality/regulatory/market access | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/09/Javier-300x300.png (actual current team image link) | | Joan Adan | VP operational finance; not current CFO | [Current team](https://www.inbrain.tech/inbrain-team/) | https://www.inbrain.tech/wp-content/uploads/2023/08/joan-adan-300x300.png (actual current team image link) | Additional legacy portraits, explicitly not evidence of current titles: - Matteo Donega: https://v2.inbrain-neuroelectronics.com/wp-content/uploads/2023/09/Matteo-Donega-400x400.png - Javier Castillo: https://v2.inbrain-neuroelectronics.com/wp-content/uploads/2023/09/Javier-Castillo-400x400.png - Joan Adan: https://v2.inbrain-neuroelectronics.com/wp-content/uploads/2023/08/joan-adan-400x400.png All three were extracted from legacy official HTML `img src`; use the current page for their current roles. Michel Decré is an advisor/former board member (2020–2024), not current company CEO. ## Financing ledger | Date | Amount | Type | Named investors | Evidence | |---|---|---|---|---| | June2020 | Undisclosed | Seed | Asabys Partners and Alta Life Sciences co-lead; ICF, Finaves, BStartup | [Primary spinout institution CSIC](https://www.imb-cnm.csic.es/es/noticias-divulgacion/noticias/la-spin-inbrain-neuroelectronics-consigue-mas-millones) | | 2021-03-26 | EUR14.35M | SeriesA | Asabys/Alta co-lead; Vsquared Ventures, TruVenturo, CDTI | [CSIC institution announcement](https://www.imb-cnm.csic.es/es/noticias-divulgacion/noticias/la-spin-inbrain-neuroelectronics-consigue-mas-millones) | | 2024-10-29 | USD50M | SeriesB | imec.xpand lead; EIC Fund, Fond-ICO Next Tech, CDTI-Innvierte, Avançsa, existing Asabys, Aliath Bioventures, Vsquared | [Investor announcement](https://asabys.com/inbrain-neuroelectronics-raises-50m-series-b-to-advance-graphene-based-brain-computer-interface-technology/); [issuer press release](https://www.asebio.com/sites/default/files/2024-10/20241029_INBRAIN_Neuroelectronics_Series_B_FINAL_PR.pdf) | | 2025 | Undisclosed | Strategic investment | Mayo Clinic; company timeline acknowledges investment, amount not established | [Official company](https://www.inbrain.tech/) | Merck support/partnership is acknowledged in the SeriesB announcement; no amount established and not a separately quantified financing round. No completed company acquisition or IPO established here. ## Review / import decision Enrich existing `InbrainNeuroelectronics` and review duplicate legal-name entity `INBRAINNEUROELECTRONICSSL` for consolidation. Preserve role changes, especially Garrido and Joan Adan. Do not duplicate the €14.35M round as a separate $17M round: it is a currency rendering of the same event. Hold precise founded year/current cumulative funding until reconciliation.
team@apexlogos.ai19 days ago
COMPETITION